Corebridge Financial’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-22,059	Closed	-$71.3K	–	967
2025 Q1	$71.3K	Sell	22,059 -2,979	-12%	-$9.62K	﹤0.01%	2606
2024 Q4	$139K	Sell	25,038 -1,890	-7%	-$10.5K	﹤0.01%	2387
2024 Q3	$291K	Buy	26,928 +120	+0.4%	+$1.3K	﹤0.01%	2010
2024 Q2	$563K	Buy	+26,808	New	+$563K	﹤0.01%	1629